Korean J Nosocomial Infect Control.
2008 Jun;13(1):32-41.
Multicenter Surgical Site Infections Surveillance System Report, 2007: In Total Hip and Total Knee Arthroplasties and Gastrectomies
- Affiliations
-
- 1Department of Infectious Diseases, Dongguk University International Hospital, Goyang, Korea.
- 2Infection Control Office, Dongguk University International Hospital, Goyang, Korea.
- 3Division of Infectious Diseases, Gachon University Gil Medical Center, Incheon, Korea.
- 4Infection Control Unit, Gachon University Gil Medical Center, Incheon, Korea.
- 5Division of Infectious Diseases, Korea University Anam Hospital, Seoul, Korea.
- 6Infection Control Unit, Korea University Anam Hospital, Seoul, Korea.
- 7Division of Infectious Diseases, Seoul National University Bundang Hospital, Seongnam, Korea.
- 8Infection Control Service, Seoul National University Bundang Hospital, Seongnam, Korea.
- 9Department of Infectious Diseases, Ajou University Hospital, Suwon, Korea.
- 10Infection Control Office, Ajou University Hospital, Suwon, Korea.
- 11Division of Infectious Diseases, Wonju Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 12Department of Laboratory Medicine, Wonju Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 13Infection Control Unit, Wonju Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
- 14Department of Hospital Infection Control, Ewha Womans University Mokdong Hospital, Seoul, Korea. heechoi@ewha.ac.kr
- 15Division of Infectious Diseases, Ewha Womans University Mokdong Hospital, Seoul, Korea.
Abstract
-
BACKGROUND: A prospective multicenter study was performed to make a surgical site infections (SSI) surveillance system for hip (HRA) and knee (KRA) replacement arthroplasties and gastrectomies (GAST) in Korea. The rates, risk factors, and clinical characteristics of SSI were evaluated.
METHODS
Demographic data, clinical and operative risk factors for SSI, and information of prophylactic antibiotic uses for the patients who took HRA/KRA and GAST in 7 and 5 hospitals, respectively were collected during July through December of 2007. SSI surveillance for HRA/KRA and GAST was done for 1 year and 1 month after operations, respectively.
RESULTS
A total of 1,294 cases (HRA, 342; KRA, 453; GAST, 499) were monitored for SSI. The SSI rates of HRA, KRA, and GAST were 1.75 (6/342), 1.10 (5/453), and 4.41 (22/499) per 100 operations, respectively. Diabetes mellitus (DM) was more frequently accompanied and the dates of hospitalization before operations were longer in the infected group than the non-infected group of HRA. DM was more frequently found in the infected groups of KRA and GAST. Reoperation, emergent operation, and transfusion were more frequent in the infected group of GAST. Prophylactic antibiotics were used in 1,279 operations (99%) and started within 60 minutes before skin incision in 93% (1,190/1,279). The most frequently used antibiotics were 1st generation cephalosporins. Prophylactic antibiotics were used in combination in 33 operations (3%) and the median duration of antibiotic use was 4 days (0-89).
CONCLUSION
The SSI rates of HRA, KRA, and GAST in this SSI surveillance system were 1.75, 1.10, and 4.41 per 100 operations, respectively.